The PE Ratio as of December 2024 (TTM) for Sonoma Pharmaceuticals, Inc. (SNOA) is -2.71

According to Sonoma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.71. This represents a change of 229.93% compared to the average of -0.82 of the last 4 quarters.

Sonoma Pharmaceuticals, Inc. (SNOA) Historical PE Ratio (quarterly & annually)

How has SNOA PE Ratio performed in the past?

The mean historical PE Ratio of Sonoma Pharmaceuticals, Inc. over the last ten years is -0.98. The current -2.71 PE Ratio has changed 27.63% with respect to the historical average. Over the past ten years (40 quarters), SNOA's PE Ratio was at its highest in in the September 2020 quarter at 35.01. The PE Ratio was at its lowest in in the September 2021 quarter at -32.70.

Sonoma Pharmaceuticals, Inc. (SNOA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sonoma Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sonoma Pharmaceuticals, Inc. (SNOA) Average PE Ratio

How has SNOA PE Ratio performed in the past?

The current PE Ratio of Sonoma Pharmaceuticals, Inc. (SNOA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sonoma Pharmaceuticals, Inc. (SNOA) PE Ratio vs. Peers

How is SNOA’s PE Ratio compared to its peers?

Sonoma Pharmaceuticals, Inc.’s PE Ratio is less than China Pharma Holdings, Inc. (-0.66), less than Universe Pharmaceuticals INC (-0.12), less than Acorda Therapeutics, Inc. (-0.00), less than Akanda Corp. (-0.04), less than Petros Pharmaceuticals, Inc. (-0.26), less than Sunshine Biopharma, Inc. (-0.90), less than Guardion Health Sciences, Inc. (0.65), greater than Alpha Teknova, Inc. (-10.79), less than Cannara Biotech Inc. (10.07), greater than MC Endeavors, Inc. (-20.25), less than Unrivaled Brands, Inc. (-1.51), greater than GelStat Corporation (-3.76), less than Shionogi & Co., Ltd. (12.13), greater than Alimera Sciences, Inc. (-20.50), less than China SXT Pharmaceuticals, Inc. (-0.05), less than Shuttle Pharmaceuticals Holdings, Inc. (-0.19), less than Lifecore Biomedical, Inc. (33.18), less than Mallinckrodt plc (-0.04), greater than Journey Medical Corporation (-5.10),

Build a custom stock screener for Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonoma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sonoma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.